Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

AGA Clinical Practice Guideline on Fecal Microbiota–Based Therapies for Select Gastrointestinal Diseases
Anne F. Peery, Colleen Kelly, Dina Kao, et al.
Gastroenterology (2024) Vol. 166, Iss. 3, pp. 409-434
Open Access | Times Cited: 63

Showing 1-25 of 63 citing articles:

Short-Chain Fatty Acids and Human Health: From Metabolic Pathways to Current Therapeutic Implications
Sonia Facchin, Luisa Bertin, Erica Bonazzi, et al.
Life (2024) Vol. 14, Iss. 5, pp. 559-559
Open Access | Times Cited: 56
Fecal microbiota transplantation: current challenges and future landscapes
Abbas Yadegar, Haggai Bar‐Yoseph, Tanya Monaghan, et al.
Clinical Microbiology Reviews (2024) Vol. 37, Iss. 2
Open Access | Times Cited: 49
A Comparison of Currently Available and Investigational Fecal Microbiota Transplant Products for Recurrent Clostridioides difficile Infection
Y Wang, Aaron Hunt, Larry H. Danziger, et al.
Antibiotics (2024) Vol. 13, Iss. 5, pp. 436-436
Open Access | Times Cited: 8
Faecal (or intestinal) microbiota transplant: a tool for repairing the gut microbiome
Rohma Ghani, Despoina Chrysostomou, Lauren A. Roberts, et al.
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 7
The Progression of Microbiome Therapeutics for the Management of Gastrointestinal Diseases and Beyond
Jessica R. Allegretti, Sahil Khanna, Benjamin H. Mullish, et al.
Gastroenterology (2024) Vol. 167, Iss. 5, pp. 885-902
Closed Access | Times Cited: 6
Live Biotherapeutic Products for the Prevention of Recurrent Clostridioides difficile Infection
Natasha N. Pettit, Kristy M. Shaeer, Elias B. Chahine
Annals of Pharmacotherapy (2024)
Closed Access | Times Cited: 4
Current and future microbiome-based therapies in inflammatory bowel disease
Jonathan A. Montrose, Satya Kurada, Monika Fischer
Current Opinion in Gastroenterology (2024) Vol. 40, Iss. 4, pp. 258-267
Closed Access | Times Cited: 4
Navigating treatment resistance: Janus kinase inhibitors for ulcerative colitis
Jonathan Soldera
World Journal of Clinical Cases (2024) Vol. 12, Iss. 24, pp. 5468-5472
Open Access | Times Cited: 4
Bile acids impact the microbiota, host, and C. difficile dynamics providing insight into mechanisms of efficacy of FMTs and microbiota-focused therapeutics
Arthur S. McMillan, Casey M. Theriot
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 4
The evolving landscape of live biotherapeutics in the treatment of Clostridioides difficile infection
Parul Berry, Sahil Khanna
Indian Journal of Gastroenterology (2025)
Closed Access
Safety and Efficacy of Fecal Microbiota, Live-jslm, in Preventing Recurrent Clostridioides difficile Infection in Mildly to Moderately Immunocompromised Participants in the Phase 3 PUNCH CD3-OLS Study
Carolyn D. Alonso, Glenn Tillotson, Monique R. Bidell, et al.
Open Forum Infectious Diseases (2025) Vol. 12, Iss. 4
Open Access
RCPE in association with the American College of Gastroenterology and the Scottish Society of Gastroenterology – Gastroenterology: A global perspective
Jennifer Murray, Amirhosein Kefayat, Mhairi Finlayson, et al.
The Journal of the Royal College of Physicians of Edinburgh (2025)
Closed Access
Effects of Lyophilized Fecal Filtrate Compared with Lyophilized Donor Stool for Preventing Recurrent Clostridioides Difficile Infection: A Multi-Center, Randomized, Double-Blinded Trial
Dina Kao, Karen Wong, Christine Lee, et al.
(2025)
Closed Access
Management of severe and fulminant Clostridioides difficile infection in adults
Daisy Ubsdell, Nicola Louise Maddox, Ray Sheridan
Journal of Medical Microbiology (2025) Vol. 74, Iss. 4
Closed Access
Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection Can Be the Best Therapeutic Option in Severely Immunocompromised Patients Depending on a Case-by-Case Assessment of the Benefit-to-Risk Ratio
Nicolas Benech, Nadim Cassir, Tatiana Galperine, et al.
Gastroenterology (2024) Vol. 167, Iss. 3, pp. 627-628
Open Access | Times Cited: 3
Gut microbiota in Crohn’s disease pathogenesis
Doğukan Özbey, Suat Sarıbaş, Bekir Kocazeybek
World Journal of Gastroenterology (2025) Vol. 31, Iss. 6
Closed Access
Optimal Approaches to Treating and Preventing Acute and Chronic Pouchitis by Altering Microbial Profiles
Govind Kallumkal, Edward L. Barnes
Gastroenterology Clinics of North America (2025) Vol. 54, Iss. 2, pp. 469-483
Closed Access
Management of Recurrent Clostridioides difficile Infection (rCDI): A Systematic Literature Review to Assess the Feasibility of Indirect Treatment Comparison (ITC)
Johanna Eliasson Vinterberg, Julia Oddsdottir, Mavis Nye, et al.
Infectious Diseases and Therapy (2025)
Open Access
Optimizing Therapeutic Potential of Fecal Transplant in Inflammatory Bowel Disease
Samantha Magier, Thomas S. Morley, Colleen Kelly
Gastroenterology Clinics of North America (2025)
Closed Access
Safety and Efficacy of Fecal Microbiota, Live-jslm (REBYOTA®), for the Prevention of Recurrent Clostridioides difficile Infection in Participants With Inflammatory Bowel Disease in PUNCH CD3-OLS
Jessica R. Allegretti, Paul Feuerstadt, W Knapple, et al.
Inflammatory Bowel Diseases (2025)
Closed Access
Das gastrointestinale Mikrobiom – Vision und Mission
Andreas Stallmach
DMW - Deutsche Medizinische Wochenschrift (2025) Vol. 150, Iss. 04, pp. 157-162
Closed Access
Unveiling roles of beneficial gut bacteria and optimal diets for health
Thallapuranam Krishnaswamy Suresh Kumar, Riya Mukherjee, Pratibha Gaur, et al.
Frontiers in Microbiology (2025) Vol. 16
Open Access
A practical approach to positioning therapies in ulcerative colitis
Russell Yanofsky, David T. Rubin
Journal of the Canadian Association of Gastroenterology (2025) Vol. 8, Iss. Supplement_2, pp. S6-S14
Open Access
Body mass index changes after fecal microbiota transplantation for recurrent Clostridioides difficile infection
Kanika Sehgal, Parul Berry, Janice Cho, et al.
Therapeutic Advances in Gastroenterology (2025) Vol. 18
Open Access
Impact of Fecal Microbiota Transplant Formulations, Storage Conditions, and Duration on Bacterial Viability, Functionality, and Clinical Outcomes in Patients with Recurrent Clostridioides difficile Infection
Mohamed Shaheen, Chelsea McDougall, Leona Chan, et al.
Microorganisms (2025) Vol. 13, Iss. 3, pp. 587-587
Open Access
Page 1 - Next Page

Scroll to top